Roche Acquires Innovatis AG for its Product Portfolio in Cellular Analytics

April 10, 2009

Roche (Basel, Switzerland) will acquire 100% of Innovatis, AG (Bielefeld, Germany).

Roche (Basel, Switzerland) will acquire 100% of Innovatis, AG (Bielefeld, Germany). Innovatis is a provider of automated cell analysis solutions, especially focusing on cell counting, viability testing, and cell function analysis in research and bioproduction.

Innovatis will become a fully integrated part of Roche Applied Science, a global business area of the diagnostic division of Roche. The company will continue to develop and market products for cell analysis through Roche Applied Science’s worldwide network. The purchase price for this transaction is €15 million.